Literature DB >> 8628793

Transcutaneous PO2 of the scalp in male pattern baldness: a new piece to the puzzle.

B E Goldman1, D M Fisher, S L Ringler.   

Abstract

Our study was designed to measure the transcutaneous PO2 of the scalp to determine if there was a relative microvascular insufficiency and associated tissue hypoxia in areas of hair loss in male pattern baldness. A controlled prospective study was performed at Butterworth Hospital, Grand Rapids, Michigan. Eighteen nonsmoking male volunteers aged 18 years and older were studied. Nine men had male pattern baldness (Juri degree II or III), and nine were controls (no male pattern baldness). Scalp temperature and transcutaneous PO2 were obtained at frontal and temporal sites in each subject. Peripheral circulation was assessed from postocclusive transcutaneous PO2 recovery time by means of maximum initial slope measurements. Statistical significance was assessed at p < 0.05. There was no significant difference in scalp temperature between male pattern baldness subjects and controls. Temporal scalp blood flow was significantly higher than frontal scalp blood flow in male pattern baldness subjects; however, there was no significant difference in controls. Transcutaneous PO2 was significantly lower in bald frontal scalp (32.2 +/- 2.0 mmHg) than in hair-bearing temporal scalp (51.8 +/- 4.4 mmHg) in men with male pattern baldness. In controls, there was no significant difference in transcutaneous PO2 of frontal scalp (53.9 +/- 3.5 mmHg) and temporal scalp (61.4 +/- 2.7 mmHg). Transcutaneous PO2 also was significantly lower in the frontal scalp of male pattern baldness subjects (32.2 +/- 2.0 mmHg) than in either frontal or temporal scalp of controls (53.9 +/- 3.5 mmHg and 61.4 +/- 2.7 mmHg, respectively). There is a relative microvascular insufficiency to regions of the scalp that lose hair in male pattern baldness. We have identified a previously unreported tissue hypoxia in bald scalp compared with hair-bearing scalp.

Entities:  

Mesh:

Year:  1996        PMID: 8628793     DOI: 10.1097/00006534-199605000-00003

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  11 in total

Review 1.  Drug discovery for alopecia: gone today, hair tomorrow.

Authors:  Zenildo Santos; Pinar Avci; Michael R Hamblin
Journal:  Expert Opin Drug Discov       Date:  2015-02-09       Impact factor: 6.098

Review 2.  Botulinum Toxin Off-Label Use in Dermatology: A Review.

Authors:  Anna Campanati; Emanuela Martina; Katia Giuliodori; Veronica Consales; Ivan Bobyr; Annamaria Offidani
Journal:  Skin Appendage Disord       Date:  2017-02-01

3.  Relation of urinary stone disease with androgenetic alopecia and serum testosterone levels.

Authors:  Emre Can Polat; Levent Ozcan; Alper Otunctemur; Emin Ozbek
Journal:  Urolithiasis       Date:  2016-05-07       Impact factor: 3.436

4.  The Effects of Ischemia and Hyperoxygenation on Hair Growth and Cycle.

Authors:  Harunosuke Kato; Kahori Kinoshita; Natsumi Saito; Koji Kanayama; Masanori Mori; Natsumi Asahi; Ataru Sunaga; Katsutoshi Yoshizato; Satoshi Itami; Kotaro Yoshimura
Journal:  Organogenesis       Date:  2020-07-30       Impact factor: 2.500

5.  Use of Botulinum Toxin for Androgenic Alopecia: A Systematic Review.

Authors:  Robert S English; Sophia Ruiz
Journal:  Skin Appendage Disord       Date:  2021-09-08

6.  Enhancing the Angiogenic and Proliferative Capacity of Dermal Fibroblasts with Mulberry (Morus alba. L) Root Extract.

Authors:  Jisoo Im; Jiyu Hyun; Sung-Won Kim; Suk Ho Bhang
Journal:  Tissue Eng Regen Med       Date:  2021-10-21       Impact factor: 4.451

7.  A Pilot Study to Evaluate Effectiveness of Botulinum Toxin in Treatment of Androgenetic Alopecia in Males.

Authors:  Sehdev Singh; Shekhar Neema; Biju Vasudevan
Journal:  J Cutan Aesthet Surg       Date:  2017 Jul-Sep

8.  Hair follicle characteristics as early marker of Type 2 Diabetes.

Authors:  J Jaime Miranda; Alvaro Taype-Rondan; Jose Carlos Tapia; Maria Gabriela Gastanadui-Gonzalez; Ricardo Roman-Carpio
Journal:  Med Hypotheses       Date:  2016-08-16       Impact factor: 4.411

9.  Effectiveness and Safety of Botulinum Toxin Type A in the Treatment of Androgenetic Alopecia.

Authors:  Yaguang Zhou; Shui Yu; Jimin Zhao; Xinyue Feng; Meinan Zhang; Zigang Zhao
Journal:  Biomed Res Int       Date:  2020-08-04       Impact factor: 3.411

Review 10.  Investigating the Safety and Efficacy of Platelet-Rich Plasma (PRP) Treatment for Female Androgenetic Alopecia: Review of the Literature.

Authors:  Santo Raffaele Mercuri; Giovanni Paolino; Matteo Riccardo Di Nicola; Laura Vollono
Journal:  Medicina (Kaunas)       Date:  2021-03-25       Impact factor: 2.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.